Bio-Rad Laboratories (Bio-Rad Laboratories) 3-Year Revenue Growth Rate : 2.70% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories 3-Year Revenue Growth Rate?

Bio-Rad Laboratories's Revenue per Share for the three months ended in Dec. 2023 was $23.66.

During the past 12 months, Bio-Rad Laboratories's average Revenue per Share Growth Rate was -2.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Bio-Rad Laboratories was 21.50% per year. The lowest was -1.80% per year. And the median was 8.00% per year.

Competitive Comparison of Bio-Rad Laboratories's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Bio-Rad Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Rad Laboratories's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's 3-Year Revenue Growth Rate falls into.

Bio-Rad Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Bio-Rad Laboratories (NYSE:BIO.B) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Bio-Rad Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BIO:USA BUWA:Germany

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.